The Role of Bcl-xL Protein in Viral Infections

被引:10
|
作者
Wyzewski, Zbigniew [1 ]
switlik, Weronika [2 ]
Mielcarska, Matylda Barbara [3 ]
Gregorczyk-Zboroch, Karolina Paulina [3 ]
机构
[1] Cardinal Stefan Wyszynski Univ Warsaw, Inst Biol Sci, PL-01815 Warsaw, Poland
[2] Warsaw Univ Life Sci SGGW, Inst Biol, Dept Biochem & Microbiol, PL-02787 Warsaw, Poland
[3] Warsaw Univ Life Sci, Inst Vet Med, PL-02787 Warsaw, Poland
关键词
Bcl-xL; HBV; HCV; HIV; IAV; EBV; HTLV-1; MRBV; SBV; CoV; EPSTEIN-BARR-VIRUS; HEPATITIS-C VIRUS; MARABA VIRUS; CELL-DEATH; NEUROCOGNITIVE DISORDER; INDEPENDENT PATHWAYS; PROMOTES SURVIVAL; OXIDATIVE STRESS; IN-VITRO; APOPTOSIS;
D O I
10.3390/ijms22041956
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bcl-xL represents a family of proteins responsible for the regulation of the intrinsic apoptosis pathway. Due to its anti-apoptotic activity, Bcl-xL co-determines the viability of various virally infected cells. Their survival may determine the effectiveness of viral replication and spread, dynamics of systemic infection, and viral pathogenesis. In this paper, we have reviewed the role of Bcl-xL in the context of host infection by eight different RNA and DNA viruses: hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), influenza A virus (IAV), Epstein-Barr virus (EBV), human T-lymphotropic virus type-1 (HTLV-1), Maraba virus (MRBV), Schmallenberg virus (SBV) and coronavirus (CoV). We have described an influence of viral infection on the intracellular level of Bcl-xL and discussed the impact of Bcl-xL-dependent cell survival control on infection-accompanying pathogenic events such as tissue damage or oncogenesis. We have also presented anti-viral treatment strategies based on the pharmacological regulation of Bcl-xL expression or activity.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [41] Sequence of Bcl-XL antisense oligonucleotides
    Tari, AM
    BLOOD, 1999, 94 (03) : 1142 - 1143
  • [42] Bcl-xL as an antiapoptotic molecule for cardiomyocytes
    Ogata, Y
    Takahashi, M
    DRUG NEWS & PERSPECTIVES, 2003, 16 (07) : 446 - 452
  • [43] BCL-XL as a tumour prognostic factor?
    Karczmarek-Borowska, Bozenna
    Zmorzynski, Szymon
    Filip, Agata
    Wojcierowski, Jacek
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2010, 14 (01): : 7 - 10
  • [44] Nutritional Regulators of Bcl-xL in the Brain
    Park, Han-A
    Broman, Katheryn
    Stumpf, Allison
    Kazyak, Sara
    Jonas, Elizabeth A.
    MOLECULES, 2018, 23 (11):
  • [45] Bcl-XL protein levels determine apoptotic index in pancreatic carcinoma
    Sharma, J
    Srinivasan, R
    Majumdar, S
    Mir, S
    Radotra, BD
    Wig, JD
    PANCREAS, 2005, 30 (04) : 337 - 342
  • [46] THERAPEUTIC EFFECT BY TARGETING BCL-XL PROTEIN IN UROTHELIAL CARCINOMA CELLS
    Yoshimine, Shunsuke
    Kikuchi, Eiji
    Kosaka, Takeo
    Miyajima, Akira
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2014, 191 (04): : E230 - E230
  • [47] Beyond apoptosis, Bcl-xL in metastasis
    Choi, Soyoung
    Chen, Zhengming
    Tang, Laura
    Fang, Yuanzhang
    Li, Yi
    Jiang, Xuejun
    Du, Yi-Chieh Nancy
    CANCER RESEARCH, 2016, 76
  • [48] Bcl-xl expression in multiple myeloma
    S. D. P. W. M. Peeters
    S. Hovenga
    S. Rosati
    E. Vellenga
    Medical Oncology, 2005, 22 : 183 - 190
  • [49] Silencing Bcl-XL in cancer therapy
    Kim, KH
    CANCER BIOLOGY & THERAPY, 2005, 4 (04) : 398 - 399
  • [50] Protein oligomerization mediated by the transmembrane carboxyl terminal domain of Bcl-XL
    Ospina, Angelica
    Lagunas-Martinez, Alfredo
    Pardo, Julian
    Carrodeguas, Jose A.
    FEBS LETTERS, 2011, 585 (19) : 2935 - 2942